The major long-term goals of the jointly executed research activities of the neuroscience programme within DiMI are:
- to establish a molecular imaging toolbox of new non-invasive diagnostic tests for in vivo phenotyping neurodegenerative diseases;
- to develop molecular imaging approaches for non-invasive monitoring of novel molecular therapies for neurodegenerative diseases;
- to use these molecular imaging tools for translational research from animal models to clinical application for early disease detection, follow-up disease progression and the effectiveness of therapeutic intervention.
Current areas of major development in neuroscience are included in the DiMI programme, and comprise
- phenotyping and early detection of neurodegeneration by multimodal imaging;
- identifying new surrogate (imaging) markers;
- imaging neuroinflammation and the potential of stem cells for activation or transplantation and their specific actions (proliferation, migration, differentiation) in terms of targeted repair.
Activities in the field of integration, training and dissemination are covered by: